The common assumption is that employees with normal test levels and negative medical history are therefore
Cincinnati (PRWEB) July 23, 2008
Health informatics firm Allostatix LLC will host a webinar titled Predicting Future Wellness: Improving Employee Health and Cost Savings, on Wednesday, July 30 at 1-2 p.m. Eastern time.
A healthy workforce benefits employers with decreased absenteeism; happier, more productive employees; and better control over rising healthcare benefits costs. Yet most existing health risk assessments miss a critical segment of the employee population – those without visible indicators of illness who are on a negative health trajectory by their reaction to accumulating stress.
Gordon Horwitz, founder and chief executive officer of Cincinnati startup Allostatix, LLC, will discuss how this accumulated stress – a person’s allostatic load – is a reliable predictor of health problems in the near future.
“The common assumption is that employees with normal test levels and negative medical history are therefore “healthy” and “low-risk,” said Horwitz. “However, testing for the allostatic load provides a picture of “whole body health” – a much more accurate approach than self-reported health behaviors or isolated tests that do not provide a comprehensive picture of health.”
This webinar examines how the daily stresses of life can build up over time and lead to expensive medical problems, and how a new test can actually predict future health status with over 80 percent accuracy. Participants will learn:
- The concept and background of allostatic load
- How stress affects overall health
- What most health risk assessments miss
- How predicting wellness can save an organization money
To sign up for the complementary webinar, visit http://www.hr.com/stories/1215803933168
About Allostatix, LLC.
Allostatix LLC is the creator of the Allostatix Load Test™, a scientific tool that measures the cumulative impact of daily life stresses on an individual’s whole body health. The company’s predictive measurement is conducted through a blood and biometric analysis and is based on 25 years of longitudinal medical research. Allostatix’s Scientific Advisory Board consists of industry-leading research MDs and PhDs from UCLA, Rockefeller University, the University of Pittsburgh and the University of Cincinnati.
More information is available at http://www.allostatix.com or via e-mail at getanswers(at)allostatix.com.
Fisher Vista for Allostatix
This press release was distributed through eMediawire by Human Resources Marketer (HR Marketer: http://www.HRmarketer.com) on behalf of the company